Publications
|
|
|
Year
|
Volume and issue
|
Articles
|
|
|
|
2013
|
January 2013
|
Sarma P, Radhika A, Chakrabarti A, Medhi B. Newer Antiepileptic Drugs. 2013 38(2): 1-45
|
April 2013
|
Shyambalaji A, Sarma P, Medhi B, Chakrabarti A. Lifestyle drugs. 2013 38(2): 1-21
|
July 2013
|
Krishnamurthy B, Medhi B. Gestational Diabetes Mellitus. 2013 38(3): 1-29
|
October 2013
|
Bhagat R, Kumar H, Sarma P, Singh S, Chakrabarti A, Medhi B. Orphan Drug and Disease. 2013 38(4): 1-27
|
2014
|
January 2014
|
Singh S, Chandel S, Bhagat R, Medhi B. Quality of Medicine. Drug bulletin 2014:39 (1): 1-5
|
April 2014
|
Radhika A, Sarma P, Medhi B. Personalized therapy: Current prospects and practical implications. Drug bulletin 2014: 39 (2): 1-9
|
July 2014
|
Bhagat R, Kumar H, Sarma P, Mishra A, Medhi B. Drug eluting stents. Drug Bulletin 2014: 39 (3): 1-9
|
October 2014
|
Reddy DH, Soni H, Chandel S, Medhi B. Post stroke dementia and treatment. Drug Bulletin 2014: 39 (4): 1-8
|
2015
|
January 2015
|
Soni S, Sarma P, Medhi B. Materivigilance: Indian perspective. Drug bulletin 2015: 40 (1): 1-15
|
April 2015
|
Rohila R, Kumar P, Naveen M, Medhi B. Novel ocular drug delivery methods. Drug Bulletin 2015. 40(2): 1-10
|
July 2015
|
Krishnamurthy B, Medhi B. MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT. Drug Bulletin 2015; 40(3): 1]17.
|
October 2015
|
Mothsara C, Patil A. Alternative therapy, Safety and efficacy: A Critical analysis with respect to Indian scenario. Drug Bulletin 2015; 40(4): 1-8
|
2016
|
January 2016
|
Sahoo S, Padhy SK, Avasthi A. An update on the newer antipsychotics: last decade. Drug Bulletin 2016; 41(1): 1-12
|
April 2016
|
Mahendru D, Kumar S, Kaur S, Prakash A, Medhi B. Sports medicine team: the background players behind a successful athlete. Drug Bulletin 2016; 41(2): 1-14.
|
July 2016
|
Vishwas G, Kakkar K A. Newer Antimicrobials and Real World. Drug Bulletin 2016; 41(3): 1-9
|
October 2016
|
CVN H, Prakash A. Snake Bite. Drug Bulletin 2016; 41(4): 1-12.
|
2017
|
January 2017
|
Thota P, Thota A, Sarma P, Prakash A, Medhi B. The startle reality of medication errors in India: role of pharmacovigilance. Drug Bulletin 2017; 42(1): 1-4.
|
April 2017
|
Manav J, Ajay P, Bikash M. Research and development in the management of HIV: Imposition of Newer drug therapy: Drug Bulletin 2017; 42(2): 1-19
|
July 2017
|
Kondel R, Pandey AK, Gani Rather II, Medhi B. Hypertension and adherence. Drug Bulletin 2017; 42(3): 1-12.
|
October 2017
|
Mishra A, Singla R,Sarma P, Rajput R,Sharma AR, Medhi B. Pharmacotherapy of Autism. Drug Bulletin 2017; 42(4): 1-14.
|
2018
|
January 2018
|
Jain A, Prakash A, Medhi B. Orphan drugs. Drug Bulletin 2018; 43(1): 1-6.
|
April 2018
|
Mahajan E, Medhi B. Memory Enhancer? Drug Bulletin 2018; 43(2):1-8
|
July 2018
|
Boparai JK, Medhi B, Singh S. Asthma, a chronic inflammatory respiratory disease: An update. Drug bulletin 2018; 43 (3): 1-14.
|
October 2018
|
Dhir N, Prakash A, Medhi B. Current updates in the management of acute ischemic stroke. Drug Bulletin 2018; 43(4): 1-6.
|
2019
|
January 2019
|
Vel K, Ajay P, Bikash M. Stem Cell Research: Current Update On Efficacy and Safety. Drug Bulletin 2019; 44(1): 1-6.
|
April 2019
|
Devraj, Medhi B. Swine Flu. Drug Bulletin 2019; 44(2): 1-11.
|
July 2019
|
Singh A, Singh RS, Sarma P, Kaur H, Mahendiratta S, Batra G, Sharma AJ, Medhi B. Current drug therapies under development in Celiac disease. Drug Bulletin 2019; 44(3): 1-7.
|
October 2019
|
Mahajan S, Tandon V, Gupta B. Pharmacotherapy of postpartum depression. Drug Bulletin 2019; 44(4): 1-10.
|
2020
|
January 2020
|
Table of Contents:
1. Bhattacharjee S, Medhi B. Management of Hepatitis C- Current Update. Drug Bulletin 2020; 45: 1-7.
2. Mahendru D, Vidya M. Mahalmani, Kumaravel J, Gitika Batra, Prakash A, Medhi B. Recent advances in treatment of myasthenia gravis. Drug Bulletin 2020; 45: 8-15.
3. Semwal A, Kaur S, Prakash A, Medhi B. Drug Therapy for recent viral epidemic & pandemic. Drug Bulletin 2020; 45: 16-22.
|
April 2020
|
Table of Contents:
1. Goyal PK, Prakash A, Medhi B. Drug addiction and rehabilitation. Drug Bulletin 2020; 45: 23-30.
2. Mahajan E, Medhi B. Newer Iron preparations: Comparative efficacy and safety in Iron deficiency anemia. Drug Bulletin 2020; 45: 31-35.
3. Jain M, Prakash A, Medhi B. Management of Dyslipidemia. Drug Bulletin 2020; 45: 36-41.
|
July 2020
|
Table of Contents:
1. Singh A, Yadav M, Kumaravel J, Sharma AR, Mishra A, Prakash A, Medhi B. E-prescription (CPOE) in Indian hospitals: A strategy to prevent prescription errors. Drug Bulletin 2020; 45: 42-51.
2. Chhimpa N, Saifuddin PK, Kaur H, Sidhu SK, Puri N, Shree R. Pharmacotherapy of Alzheimer’s Disease. Drug Bulletin 2020; 45: 52-63.
3. Venkatesan N, Thangaraju P, Varthya SB, Gurunthalingam MP, Venkatesan S, Thangaraju E. Learning pharmacology of Monoclonal Antibodies through Metaphors- Need of the hour. Drug Bulletin 2020; 45: 64-72.
|
October 2020 |
Table of Contents:
1. Venkatesan N, Thangaraju P, Varthya SB, Gurunthalingam MP, Venkatesan S, Thangaraju E. A tale of anti-arrhythmic drugs: A Metaphoric construct of learning pharmacology for medical students. Drug Bulletin 2020; 45: 73-80.
2. Mahajan E, Medhi B. Empirical Management of STDs. Drug Bulletin 2020; 45: 81-83.
3. Sharma M, Sharma AR, Singh A, Saiffuddin PK, Raja A, Medhi B. An Overview on surveillance of Biomedical Devices under Materiovigilance Program of India. Drug Bulletin 2020; 45: 84-94.
|
2021 |
January-March
2021
|
Table of Contents:
1.Jain M, Prakash A, Medhi B. Narrow therapeutic index drugs and role of Therapeutic drug monitoring. Drug Bulletin 2021; 46: 1-5.
2. Thota P, Thota A, Sarma P, Prakash A, Teotia AK, Prakash J, Medhi B. Is it Covid-19 or Dengue fever: what you need to know? Streamlined way of Differential diagnosis and management. Drug Bulletin 2021; 46: 6-13.
3. Kaur S, Medhi B. Drug Induced Liver Injury. Drug Bulletin 2021; 46: 14-19.
|
April-June 2021 |
Table of Contents:
1. Saifuddin PK, Bhattacharyya A, Sarma P, Mahendiratta S, Kaur H, Chhimba N, Prakash A, Medhi B* , Vaccines for COVID-19. Drug Bulletin 2021; 46 (2): 1-14
2. Handa V, Raja A, Dhibar DP, Medhi B, Current status on the potential Drug Therapies for COVID-19. Drug Bulletin 2021; 46(2): 15-30
3. Kaur H, Kaur C, Medhi B* , Antibiotic Resistance. Drug Bulletin 2021; 46 (2): 31-46
|
July-September
2021
|
Table of Content:
1. Jain A, Sharma S, Prakash A, Medhi B. Pharmacotherapy for low backache. Drug Bulletin 2021; 46 (3): 1-6.
2. Handa V, Kumar M, Sharma AR, Medhi B* , A Review on the Potential Toxic Consequences of AlcoholBased Sanitizers. Drug Bulletin 2021; 46 (3): 7-20.
3. Singh A, Singh RS, Masih GD, Suroy B, Sharma AJ, Batra G, Prakash A, Medhi B. Current status of Therapies in Inflammatory Bowel Disease. Drug Bulletin 2021; 46 (3): 21-36.
|
October-December 2021 |
Table of Content:
1. Prabha PK, Choudhary G, Prakash A, Medhi B. Drug approval in Rare Disease. Drug Bulletin 2021; 46 (4): 1-8.
2. Angra V, Prakash A, Medhi B. Management of Malaria. Drug Bulletin 2021; 46 (4): 9-21.
3. Tondon M, Prakash A, Medhi B. Regulatory scenario of medical devices in India. Drug Bulletin 2021; 46: 22-26.
|
2022 |
January-March 2022 |
Table of Contents:
1.Kumaravel J, Medhi B. Management of Poisoning. Drug Bulletin 2022; 47: 1-7.
2. Maheshwari S, Kumar V, Medhi B, Prakash A. Current evidence in the management of cervical spondylosis: a review. Drug Bulletin 2022; 47: 8-15.
|
April-June 2022 |
Table of Contents:
1. Sharma N, Prakash A and Medhi B. Therapeutic targets for the prevention of epilepsy. Drug Bulletin 2022; 47 (2): 17-28.
2. Suroy B et al.,Current updates in Pharmacovigilance. Drug Bulletin 2022; 47 (2): 29-56.
|
July-September 2022 |
Table of Contents:
1. Salaria D, Rolta R, Prakash A and Medhi B. Approval of food products by FSSAI. Drug Bulletin 2022; 47 (3): 57-62.
2. Joshi R, Sharma M, Priyanshi. Drugs Used in Pregnancy and Lactation. Drug Bulletin 2022; 47 (3): 63-72.
|
October-December
2022
|
Table of Contents:
1. Walter NS, Gorki V and Medhi B. Recent Trends in Drug Development in Parasitic Diseases. Drug Bulletin 2022; 47 (4): 73-82.
2. Salaria D, Rolta R, Prakash A and Medhi B. Phytopharmaceuticals approved by FSSAI. Drug Bulletin 2022; 47 (3): 84-87.
|
XX">
|